Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants
Tomas Forslund(Karolinska University Hospital), Paul Hjemdahl(Karolinska University Hospital), Björn Wettermark(Karolinska Institutet), Aukje K. Mantel‐Teeuwisse(Utrecht University), Frieder Braunschweig(Karolinska University Hospital), Morten Andersen(Karolinska Institutet), J. Komen(Utrecht University), Mia von Euler(University Hospital of North Norway)
Cited by 77
Related Papers
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
Pediatric Drug Formulations: A Review of Challenges and Progress
|PEDIATRICS|2014|318
Introduction to drug utilization research
|Unknown|2016|237
Introduction to drug utilization research
|Unknown|2024|211